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Chromatinmodifications are critical for the establish-
ment and maintenance of differentiation programs.
G9a, the enzyme responsible for histone H3 lysine 9
dimethylation in mammalian euchromatin, exists as
two isoforms with differential inclusion of exon 10
(E10) through alternative splicing. We find that the
G9a methyltransferase is required for differentiation
of the mouse neuronal cell line N2a and that E10
inclusion increases during neuronal differentiation
of cultured cells, as well as in the developing mouse
brain. Although E10 inclusion greatly stimulates
overall H3K9me2 levels, it does not affect G9a cata-
lytic activity. Instead, E10 increases G9a nuclear
localization. We show that the G9a E10+ isoform
is necessary for neuron differentiation and regulates
the alternative splicing pattern of its own pre-mRNA,
enhancing E10 inclusion. Overall, our findings indi-
cate that by regulating its own alternative splicing,
G9a promotes neuron differentiation and creates a
positive feedback loop that reinforces cellular
commitment to differentiation.
INTRODUCTION
The hundreds of different cell types found in multicellular organ-
isms show vast differences in phenotype, function, and response
to external stimuli, yet they all derive from the same zygotic cell
and share identical genetic material. This diversity arises as a
result of a complex and stepwise differentiation process that re-Cellquires activation and inactivation of transcriptional programs. In
addition to specific sets of transcription factors, it has become
clear that histone and DNA modifications are critical for both
establishment of differentiation programs and maintenance of
acquired differentiated phenotypes (Surani et al., 2007). Cova-
lent modification of histone tails proved to be a convergent point
of multiple signaling pathways and to embody an additional code
superimposed on the genetic code (Bannister and Kouzarides,
2011; Jenuwein and Allis, 2001).
G9a, also known as EHMT2 (euchromatic histone lysine
N-methyltransferase 2) and KMT1C (lysine methyltransferase
1C), is the enzyme responsible for H3K9mono- and dimethylation
(H3K9me1 and H3K9me2) in mammalian euchromatin and is
essential for early mouse development (Tachibana et al., 2002).
Mammals possess only one paralog of G9a, called GLP or
EHMT1/KMT1D. Both enzymes are characterized by a C-terminal
catalyticSETdomainprecededbyankyrin repeats that functionas
mono- and dimethyllysine binding modules (Collins et al., 2008).
G9a and GLP interact through their SET domains and are thought
to function primarily as a heteromeric complex in vivo (Liu et al.,
2015;Ohno et al., 2013). G9a knockoutmice are embryonic lethal,
and the derived embryonic stem cells show dramatically reduced
levels of H3K9me1 and H3K9me2, histone marks that are gener-
ally associated with transcriptional silencing (Kramer, 2015). In
particular, many non-histone targets of methylation by G9a have
been described (Rathert et al., 2008), including p53 (Huang
et al., 2010) and G9a itself, by automethylation (Chin et al., 2007).
G9a has been implicated in the differentiation of a variety of
cell and tissue types. G9a is essential for the differentiation
and growth of thenocytes, with the expression of several tendon
transcription factors being suppressed in G9a null cells (Wada
et al., 2015). Furthermore, G9a cooperates with Sharp-1, a
potent repressor of skeletal muscle differentiation, methylatingReports 14, 2797–2808, March 29, 2016 ª2016 The Authors 2797
MyoD and histones at the myogenin gene promoter (Ling et al.,
2012); G9a deficiency impairs differentiation of monocytes
(Wierda et al., 2015) and T helper cells (Lehnertz et al., 2010).
In the nervous system, G9a has been shown to control cogni-
tion and adaptive responses by repression of nonneuronal genes
(Schaefer et al., 2009). Its ortholog in Drosophila has been
described as a regulator of peripheral dendrite development,
classic learning, and memory genes (Kramer et al., 2011).
Moreover, G9a has been shown to influence neuronal subtype
specification (Maze et al., 2014) and regulate ethanol-induced
neurodegeneration (Subbanna et al., 2013).
Alternative splicing not only is the most important source
of mRNA and protein diversity but also greatly contributes to
tissue- and species-specific protein patterns in multicellular
eukaryotes (Barbosa-Morais et al., 2012; Ellis et al., 2012; Korn-
blihtt et al., 2013). Alternative splicing plays a role in a vast array
of normal and pathological processes including cell proliferation
and differentiation, as well as cancer and numerous diseases
(Cáceres and Kornblihtt, 2002; Faustino andCooper, 2003; Kele-
men et al., 2013; Liu et al., 2012). Pre-mRNA splicing commit-
ment occurs mostly co-transcriptionally, but the actual splicing
reaction can occur either co- or post-transcriptionally (Tilgner
et al., 2012; Vargas et al., 2011). Co-transcriptional regulation
allows for mechanistic interactions between the transcription
and splicing machineries (Bentley, 2005; Kornblihtt et al., 2013;
Neugebauer, 2002; Perales and Bentley, 2009).
Accumulating evidence points to the existence of multiple
functional links between chromatin structure and pre-mRNA
splicing (Luco et al., 2010; Naftelberg et al., 2015). Early reports
with virus and plasmid systems (Adami and Babiss, 1991; Kad-
ener et al., 2001) and more recent ones with endogenous genes
show that several histone marks deployed intragenically are
asymmetrically distributed between exons and introns (Kolasin-
ska-Zwierz et al., 2009) and modulate alternative splicing deci-
sions (Alló et al., 2009, 2014; Ameyar-Zazoua et al., 2012;
Batsché et al., 2006; Schor et al., 2009, 2013). In addition to
changes in the RNA polymerase II (RNAPII) elongation proper-
ties, chromatin marks can regulate both constitutive and alterna-
tive splicing by recruitment of splicing factors to transcription
sites (Gonzalez et al., 2015; Luco et al., 2010; Sims et al.,
2007). Using an RNAi-based screen targeting chromatin modi-
fying proteins, Salton and colleagues have recently identified
G9a as a major regulator of VEGFA alternative splicing (Salton
et al., 2014). The mechanism involves intragenic H3K9 methyl-
ation at the VEGFA locus, recruitment of the heterochromatin
protein HP1, and the splicing factor SRSF1, consistent with pre-
vious reports linking HP1 gamma to alternative splicing (Saint-
André et al., 2011). The authors demonstrated separate roles
for G9a in transcription and alternative splicing.
Here, we report that G9a is required for neuron differentiation
and that this process correlates with increased inclusion of G9a
alternative exon 10 (E10). Although E10 inclusion does not affect
G9a intrinsic catalytic activity, it results in increased H3K9me2
levels due higher nuclear localization of the enzyme and appears
to be necessary for efficient differentiation. The alternatively
spliced exon does not encode a nuclear localization signal
(NLS), but it is predicted to enhance the exposure of the neigh-
boring constitutive NLS to the external hydrophilic milieu. More-2798 Cell Reports 14, 2797–2808, March 29, 2016 ª2016 The Authorover, G9a regulates its own alternative splicing, suggesting a
positive feedback loop that upregulates H3K9me2 during cell
differentiation.
RESULTS
G9a Is Required for Neuron Differentiation
The euchromatin histone methyltransferase G9a has been re-
ported to affect the differentiation process of a variety of cells
and tissues. Here, we used a well-established model of neuronal
differentiation to study the role of G9a during the differentiation
of precursors cells into mature neurons. Neuro 2a (N2a) is a
mouse-neural-crest-derived cell line that can be differentiated
into neurons and has been extensively used to study neuronal
differentiation. N2a cells treated with 1 mM retinoic acid (RA)
for 1–3 days readily enter a differentiation program as reflected
by neurite sprouting (Figure 1A) and the increased expression of
Tau (microtubule-associated protein tau), a specific neuronal
marker (Figure 1B). Depletion of G9a in N2a using small inter-
fering RNA (siRNA) prior to the differentiation treatment
completely abolishes both neurite outgrowth (Figure 1C) and
the upregulation of Tau expression (Figure 1D). BIX-01294
(BIX) is a diazepin-quinazolin-amine derivative that selectively
inhibits G9a and GLP methyltransferase activities and has
been shown to reduce overall H3K9me2 levels in several cell
types (Chang et al., 2009; Kubicek et al., 2007; Shi et al.,
2008). N2a cells treated with BIX from the initiation of the differ-
entiation protocol begin to develop neurites but fail to fully
establish and maintain the differentiated phenotype compared
to control cells (Figure 1E). Moreover, BIX treatment completely
abolishes the increase in Tau expression during differentiation
(Figure 1F). These results confirm a role for G9a and its histone
methyltransferase activity in the differentiation of N2a cells into
neurons. To reinforce this conclusion, the abolishment of neurite
outgrowth in G9a knockdown cells can be rescued by transfect-
ing the cells with an expression construct encoding the human
wild-type G9a, but not with its catalytically dead mutant coun-
terpart (Figure 1G), strongly indicating that the effect depends
on G9a enzymatic activity.
G9a Pre-mRNA Is Alternatively Spliced during Neuron
Differentiation
Both in humans andmice,G9amRNA has two isoforms resulting
from alternative splicing of its exon 10 (E10) (Brown et al., 2001).
Although it inserts an internal segment of 33 amino acids toward
the NH2-terminal third of the protein, inclusion of E10 does not
alter the reading frame of G9a mRNA, neither does it affect any
characterized domain of the protein (Figure 2A). G9a E10 in-
clusion increases when N2a cells are subjected to the DMSO
differentiation protocol (Figure 2B). The same upregulation is
observed with the differentiation protocol that uses RA (Fig-
ure 2C) and in a different cell line, P19, in which mouse embry-
onic stem cells are induced to form embryonic bodies and later
neural cells (Figure 2D). Most importantly, E10 inclusion is upre-
gulated in whole brains from newborn mice from postnatal days
1–7 and is maintained significantly elevated for as long as
4 months after birth (Figure 2E). This regulation is not restricted
to neuron differentiation, since during T cell stimulation (Martinezs
Figure 1. G9a Is Required for Neuron Differentiation
N2a cells were differentiated by treatment with 1 mM RA for 1–3 days.
(A and B) The percentage of cells displaying neurite outgrowth (differentiated cells) was determined (A), and mRNA levels of the neuronal marker Tau was
assessed (B) by qRT-PCR and relativized using HSPCB (heat shock protein class B) as a housekeeping.
(C–F) N2a cells were transfected with G9a siRNA (siG9a) (C and D) or treated with 3 mM BIX (E and F) previously to differentiation induction and analyzed as
described in (A) and (B).
(G) Prior to differentiation induction, N2a cells were cotransfected with siG9a or luciferase siRNA (siLUC) as a control, together with rescue plasmids encoding
human Flag-tagged G9a full-length wild-type (WT) or catalytically dead mutant (mut) cDNAs. The expression of these human constructs is not downregulated by
themouse G9a siRNAs used here and along the report. Cells were fixed and Flag-tagged G9a expression was assessed by indirect immunofluorescence. In view
of the higher efficiency of siRNA transfection compared to the plasmid transfection, differentiation was only assessed in the cells showing positive fluorescence.
The plot on the right shows the percentage of differentiated cells.
Scale bars represent 10 mm. Statistical analysis corresponds to one-way ANOVA, Bonferroni post hoc test (**p < 0.001, and ***p < 0.0001).et al., 2012) and mammary gland differentiation, E10 inclusion is
also increased (Figure 2F).
E10 Inclusion Is Required for Neuron Differentiation
Since G9a is required for neuron differentiation and E10 inclusion
is upregulated in mature neurons, we sought to determine if E10Cellinclusion in G9a is responsible for promoting neuron differentia-
tion. For this, we knocked down the E10-containing mRNA
isoform using an siRNAs specifically targeting E10 sequence
(siE10). Under conditions in which total amounts of G9a mRNA
(Figure S1A) and protein (Figure S1B) levels are not affected,





Figure 2. Alternative Splicing of G9a Gene Is
Modulated during Neuron Differentiation
(A) Schematic diagram of the G9a gene showing
the alternatively spliced isoforms containing and
lacking E10.
(B and C) N2a cells were differentiated with 2%
DMSO (B) or 1 mM RA (C) for 1 to 6 days. At the
indicated time points, cells were harvested, RNA
was extracted, and alternative splicing of the G9a
gene was assessed by radioactive RT-PCR.
(D) P19 cells were differentiated with RA for 7 days
and alternative splicing of G9a was assessed as
described. RT-PCR gels are shown at the top and
the corresponding quantification at the bottom.
(E) Mouse brains were sampled at postnatal day
(PND) 1, 7, and 120. RNA was extracted, and alter-
native splicing of G9a was assessed as described.
(F) Mammary epithelial cells were differentiated with
extracellular matrix (ECM) and basal membrane
(BM) in presence of lactogenic hormones as
described in Experimental Procedures. Cells were
harvested, RNA was extracted, and alternative
splicing of the G9a gene was assessed as
described. The corresponding quantification is
shown on the right.
All experiments were performed in triplicate, and
means and SE of representative experiments are
shown. Statistical analysis corresponds to one-
way ANOVA, Bonferroni post hoc test (*p < 0.05 and
**p < 0.001).cells treated with RA (Figure 3A). The siE10 treatment causes
a significant inhibition of differentiation (Figures 3B and C),
revealing that inclusion of E10 has an crucial role in the promo-
tion of neuron differentiation by G9a.
H3K9me2 Is Increased during Neuron Differentiation
and Stimulated by E10 Inclusion
As we observed that G9a methyltransferase activity is required
for neuron differentiation, we sought to evaluate the H3K9me2
global levels in precursor and mature neural cells. After 3 days
of neuron differentiation induced by RA, N2a cells present a
significantly stronger signal of H3K9me2 compared to undiffer-
entiated cells (Figure 4A). As neuron differentiation correlates
with H3K9me2 upregulation and G9a E10 inclusion, we decided
to analyze the effect of E10 inclusion on G9a methyltransferase
activity. For this, we transfected expression vectors encoding
the two G9a isoforms (E10+ and E10) into G9a clustered regu-
larly interspaced short palindromic repeats (CRISPR)-ablated
HEK293 cells and analyzed the global H3K9me2 levels. Figure 4B
shows that H3K9 dimethylation is almost completely abolished
in the G9a knockout cells (compare lanes 1 and 2). Overexpres-
sion of bothG9a splicing isoforms partially rescue K9 dimethyla-
tion, with a stronger effect caused by the E10+ G9a variant
(compare lanes 3 and 4). These results suggest that inclusion
of E10 stimulates G9a’s ability to methylate histone targets.
Exon 10 Inclusion Does Not Affect G9a Intrinsic
Catalytic Activity
To further examine the role of E10 inclusion on G9a activity, we
used a powerful methyltransferase fluorescence resonance2800 Cell Reports 14, 2797–2808, March 29, 2016 ª2016 The Authorenergy transfer (FRET) reporter (Lin et al., 2004). In this system,
a peptide substrate corresponding to the K9 methylation site of
histone H3 is joined via a flexible linker to a methyllysine binding
domain known as a chromodomain. Upon methylation of the K9
residue, the chromodomain forms an intramolecular complex
with the methyllysine side chain, altering the spatial relationship
between flanking CFP and YFP units and changing the FRET
level (Figure 4C). In order to obtain results that were indepen-
dent from the subcellular localization of both the FRET sensor
and theG9a splicing isoforms, fluorescence data were collected
only from nuclear compartments of cells and relativized to
expression levels of the E10 or E10+ isoforms. Using this
assay, both isoforms display similar methyltransferase abilities
(Figure 4D), indicating that E10 inclusion does not stimulate
G9a catalytic activity. This observation suggests that the in-
crease in H3K9me2 levels elicited by E10 inclusion must
be caused by a mechanism different from an increase in G9a
intrinsic activity.
Exon 10 Inclusion Promotes G9a Nuclear Localization
The amino acid sequence encoded by E10 does not contain any
NLS or any other recognizable consensus for specific functions.
However, a bona fide bipartite NLS is located nine residues to-
ward the N terminus from the start of the E10-encoded segment.
Since the E10 protein sequence and the neighboring NLS are
predicted by IUPred (Dosztányi et al., 2005) to be intrinsically un-
structured, the inclusion of E10 places G9a’s NLS in a more
extended unstructured region (Figure 4E). Therefore, the disor-
der tendency of E10 could allow a structural arrangement that
modulates the accessibility of the contiguous NLS. In view ofs
Figure 3. E10 Inclusion Is Required for
Neuron Differentiation
N2a cells were differentiated by treatment with
1 mMRA (RA) or maintained undifferentiated () for
1–3 days and transfected with siLUC as a control
or G9a E10 siRNA (siE10) previously to differenti-
ation induction.
(A) Alternative splicing of G9a was assessed as
described in Figure 2, and the percentage of E10
inclusion is indicated to show the effect of the
siE10 treatment.
(B and C) The percentage of cells displaying neu-
rite outgrowth was determined morphologically
(B) and quantified (C). Scale bars represent 10 mm.
A schematic diagram of G9a gene showing the
target site of siE10 is shown (B, top).
See algo Figure S1.this, we explored the possibility that E10 inclusion regulates the
subcellular localization of G9a.
Immunofluorescence of N2a cells with an anti G9a antibody
reveals cells with distinctive patterns. In undifferentiated cells,
G9a is detected both in the nucleus and the cytoplasm. This
pattern changes radically during neuron differentiation to an
almost only nuclear localization (Figure 5A). Quantifications of
the relative concentration of fluorescence intensity either using
DMSO (Figure 5B) or RA (Figure 5C) indicate that neuron differ-
entiation significantly increases the nucleus/cytoplasm ratio.
The same results are obtained by quantifying the total fluores-
cence intensity in both cell lines (Figures S2A and S2B). Interest-
ingly, there is a positive linear correlation between the degree of
G9a E10 inclusion and the nuclear localization of G9a proteins in
four different human cell lines analyzed (Figure S2C).
In order to obtain independent evidence, we assessed G9a
localization by western blot in nuclear and cytoplasmic fractions
of undifferentiated and differentiated N2a cells. Figure 5D shows
that upon differentiation, the two protein isoforms differing by
E10 decrease in the cytoplasmic fraction (compare overall inten-
sities in lanes 1 and 3) and increase in the nuclear fraction
(compare overall intensities in lanes 2 and 4). Furthermore, the
nuclear fractions (lanes 2 and 4) display a higher E10+/ E10 pro-
tein isoform ratios.
In view of results in Figure 5A and the observed increase in E10
inclusion into G9a mRNA upon differentiation (Figure 2), we
reasoned that if E10 inclusion promotes the nuclear localization
of the protein, G9a translocation to the nucleus should be
impaired by siE10 treatment. In order to test this hypothesis,
we analyzed the subcellular localization of G9a in N2a undiffer-
entiated cells transfected with siE10. When comparing the rela-
tive concentration of G9a fluorescence intensity, siE10-treated
cells show a nucleus/cytoplasm localization ratio significantly
lower than control cells (Figure 5E).
To better determine whether E10 inclusion only correlates with
or instead causes G9a nuclear localization, we transiently ex-Cell Reports 14, 2797–2808pressed Flag-tagged cDNAs encoding
G9a with and without E10 in HeLa and
N2a cells. Recombinant G9a displays
two expression patterns in both celltypes: only nuclear (n) or nuclear and cytoplasmic (n+c) (Figures
6A and 6B). At equal expression levels, verified by western blot
(Figure 6C), expression of the E10+ isoform decreases the per-
centage of cells with the n+c pattern and increases the percent-
age of cells with the n pattern, both in HeLa (Figure 6D) and N2a
cells (Figure 6E). This indicates that inclusion of E10 promotes
the nuclear localization of the protein complexes that contain
the G9a polypeptide.
G9aRegulates Alternative Splicing of Its OwnPre-mRNA
through a Positive Feedback Loop
Extended evidence has revealed that chromatin modifications
can affect alternative splicing (Saint-André et al., 2011; Salton
et al., 2014; Schor et al., 2013; Shukla et al., 2011), and we
have shown here that E10 inclusion correlateswith increased nu-
clear localization of G9a and H3K9me2 levels. We therefore hy-
pothesized that G9a might regulate its own alternative splicing.
Treating N2a differentiated cells with the K9 methylation inhib-
itor BIX completely reverts the increase in E10 inclusion triggered
by neuron differentiation (Figure 7A). Although BIX prevents
neuronal precursors to differentiate into mature neurons, in this
case, the cells were treated after the differentiation program
was already established in order to rule out a possible inhibition
of differentiation. Indeed, BIX does not revert differentiation
when already established (Figure S3). This observation supports
the idea that G9a methyltransferase activity is required for the
regulation of its own splicing during neuron differentiation.
An immediate question emerged whether upregulation of E10
inclusion could result from changes in H3K9 methylation on the
G9a gene. Chromatin immunoprecipitation experiments show
that neuronal differentiation increases H3K9me2 in the G9a
genebodybut not at the promoter or at a distant intergenic region
(Figure S4A). As the upregulation of E10 inclusion correlates with
increased H3K9me2 levels inG9a gene, we decided to analyze if
chromatin structure plays a role in the regulation of G9a alterna-
tive splicing. The cytosine analog 5-azacytidine (5aC) and the, March 29, 2016 ª2016 The Authors 2801
Figure 4. E10 InclusionStimulatesH3K9me2
without Affecting G9a Catalytic Activity
(A) Following differentiation with 1 mM RA for
3 days, N2a cells were harvested and western blot
performed with anti-H3K9me2 and anti-total H3
antibodies.
(B) G9a CRISPR-ablated HEK293 cells were
transfected with expression plasmids encoding
mouse E10, E10+ G9a full-length cDNAs or the
corresponding empty vector. 48 hr after trans-
fection, cells were harvested and western blot
assay was performed as in (A).
(C) Schematic diagram of the methyltransferase
activity reporter (Lin et al., 2004).
(D) HeLa cells were co-transfected with expression
plasmids encoding mouse E10 or E10+ G9a iso-
forms and the methyltransferase activity reporter.
Methylation of the reporter protein was detected by
FRET as described in Experimental Procedures.
FRET data were obtained only from nuclear com-
partments of cells. Bars represent means ± SE.
Nonparametric Wilcoxon rank-sum test was used
(**p < 0.001).
(E) Predicted disorder of the polypeptides encoded
by the G9a splicing variants. The energy of each
residue of E10 (top) and E10+ (bottom) G9a iso-
forms was calculated by IUPred to assign their
order/disorder status, as described in Experimental
Procedures.histone deacetylase inhibitor trichostatin A (TSA) have been
shown to alter DNAmethylation and histone acetylation, resulting
in reduced H3K9me2 levels (Coombes et al., 2003; Fahrner et al.,
2002; Nguyen et al., 2002). In our system, both 5aC and TSA also
prevent E10 increased inclusion during neuron differentiation,
further supporting a role for histone marks in the regulation of
G9a E10 splicing (Figures S4B and S4C). Of note, bisulfite
sequencing analysis of a CpG island located in G9a intron 9
shows no changes in 5-methylcytosine upon differentiation of
N2a cells, indicating that the effect of 5aC on E10 inclusion is
not due to inhibition of DNAmethylation (Figure S4D). Altogether,
these observations suggest that chromatin structure plays a
fundamental role in the regulation of G9a alternative splicing.
To further examine the role ofG9a in the regulation of alternative
splicing of its ownpre-mRNA,weobtained aG9a splicing reporter
minigene containing exons 9–11 and their corresponding introns
(Figure S5A) which, when transfected into N2a cells, shows the
same regulation as the endogenous gene during neuron differen-
tiation (Figure S5B). PCR primers used to amplify the minigene
transcripts were designed so as to avoid detecting the G9a
expressed isoforms (Figure 7B, right three lanes). Cotransfection
of theG9asplicing reporterwith theexpression constructs encod-
ing the G9a isoforms shows that the E10+ is more powerful than
the E10 isoform in stimulating E10 inclusion in HeLa cells (Fig-
ure 7B, left three lanes). This effect is significantly reduced when
the E10+ catalytically dead mutant is overexpressed (Figure 7C).
The inhibitory effect is even stronger when expressing another
E10+mutant that also has its interactionwithGLP impaired (Tachi-
bana et al., 2008) (Figure 7D) and is also observed upon G9a
activity inhibition by treatment with BIX (Figure 7E).2802 Cell Reports 14, 2797–2808, March 29, 2016 ª2016 The AuthorTaken together, our results suggest that G9a affects its own
alternative splicing either in a direct or indirect manner. More-
over, this regulation requires interaction with GLP andG9ameth-
yltransferase activity. As G9a E10+ isoform is more potent at
promoting E10 inclusion and is required for efficient neuron dif-
ferentiation, our results are consistent with a positive loop in
which neuron differentiation favors the synthesis of the E10+ iso-
form that, in turn, promotes more inclusion of E10 and favors the
nuclear localization of the protein.
DISCUSSION
Intragenic histone modifications control alternative splicing
through either the modulation of RNAPII elongation rates or the
recruitment of adaptors and splicing factors to the pre-mRNA
that is being synthesized. The existence of such mechanisms,
which are not mutually exclusive, imposes the study of the regu-
lation of the enzymes in charge of writing the specific histone
marks that regulate alternative splicing. We have chosen G9a
because in addition to its fundamental role in the regulation of
gene expression programs triggered by cellular differentiation,
the silencing mark H3K9me2 has been shown to contribute to
several alternative splicing decisions (Saint-André et al., 2011;
Salton et al., 2014; Schor et al., 2013).
Papasaikas and colleagues have recently reported a func-
tional interaction alternative splicing network where most of the
nodes are occupied by splicing regulators with a few cases of
chromatin factors (Papasaikas et al., 2015). Interestingly, and
despite the fact that the majority of the chromatin factors appear
peripherally in the network, G9a and SUV39H1 are centrallys
Figure 5. Neuronal Differentiation Triggers
a Nuclear Accumulation of G9a Protein
N2a cells were differentiated with 2% (v/v) DMSO
or 1 mM RA for 6 or 3 days, respectively.
(A) Cells were then fixed and G9a protein locali-
zation was assessed by indirect immunofluores-
cence.
(B and C) Plots show relative concentration of
fluorescence intensity of G9a in the nuclear and
cytoplasmic compartments for N2a cells differen-
tiated with DMSO (B) or RA (C).
(D) After differentiation with 1 mM RA for 3 days,
N2a cells were harvested and nuclear and cyto-
plasmic fractions obtained and treated for dena-
turing SDS-PAGE, followed by western blot with
anti-H3, anti-GAPDH, and anti-G9a antibodies.
(E) Undifferentiated N2a cells were transfected
with siE10 or siLUC as a control and fixed for
immunofluorescence as in (A). The plot on the right
shows relative concentration of fluorescence in-
tensity of G9a in the nuclear and cytoplasmic
compartments 48 hr after transfection.
Scale bars represent 10 mm. Statistical analysis
corresponds to Student’s t test (**p < 0.001 and
***p < 0.0001). See algo Figure S2.localizedwith strong connections to core spliceosomal factors—
mainly U5 components—suggesting mechanistic cross-talks
between their function and the regulation of alternative splicing
(Figure S6).
We report here that G9a is required for neuron differentiation of
N2a cells in culture, consistent with higher H3K9me2 global
levels in differentiated cells. This observation is not surprising,
as G9a has been shown to affect a variety of differentiation path-
ways (Lehnertz et al., 2010; Ling et al., 2012; Wada et al., 2015),
in addition to its implications in the development of neural tissues
(Maze et al., 2014; Schaefer et al., 2009; Subbanna et al., 2013).
Moreover, our results show that G9a regulation takes place at
the level of alternative splicing by a positive feedback loop. We
observed that inclusion of G9a E10 increases during neuron dif-
ferentiation (Figure 2) and that the E10+ G9a isoform favors the
inclusion of E10 in the mature mRNA and is required for efficient
neuron differentiation (Figures 3B and 3C). It is likely that this
positive loop is part of the differentiation program of different
cell types, since the effect on E10 inclusion is not restricted to
neuron development (Figure 2F).Cell Reports 14, 2797–2808Multiple independent lines of evidence
demonstrate that G9a’s histone-methyl-
ating activity regulates alternative splicing
of its own pre-mRNA: differentiation-
dependent E10 inclusion is abrogated
by the inhibitor of H3K9 dimethylation
BIX 01894 (Figure 7A), by drugs that indi-
rectly promote H3K9 demethylation like
5aC and TSA (Figures S4B and S4C),
and by mutating G9a’s catalytic site
(Figures 7C and 7D). All these data
are consistent with higher levels of
H3K9me2 deployed on the G9a geneupon neuron differentiation (Figure S4A). It is important to point
out that the increase in H3K9me2 on the G9a gene was relativ-
ized to total H3, indicating that differentiation does not merely in-
crease nucleosome density on the G9a gene but changes the
quality of its histone marks. The deployment of this silencing
mark does not seem to be specific for the G9a gene, as it has
been also observed in the NCAM gene (Schor et al., 2013) as
well as in the fibronectin gene (Figure S7) upon neuron differen-
tiation. We do not rule out the possibility of an indirect mecha-
nism of G9a regulating its own alternative splicing.
Regarding the mechanism by which G9a methylating activity
regulates its own alternative splicing, one obvious inferencewould
be a positive feedback loop in which inclusion of E10 would upre-
gulateG9aenzymatic activity.However,wedemonstratehere that
E10 inclusiondoesnotaffect theenzymeactivity invivo (Figure4D).
Instead, the intrinsically unstructured nature of the E10 peptide,
characteristic of most protein segments encoded by alternatively
spliced exons (Buljan et al., 2013), might contribute to a major
exposure of a neighboring NLS (Figure 4E), suggesting that E10
inclusion promotes G9a nuclear localization. This prediction is, March 29, 2016 ª2016 The Authors 2803
Figure 6. Presence of Exon 10 Favors G9a Nuclear Localization
(A and B) HeLa (A) or N2a cells (B) were transfected with expression plasmids encoding mouse Flag-tagged E10 or E10+ G9a full-length cDNAs (corresponding
to the short isoforms according to the promoter, including the distal first exon). 48 hr after transfection, cells were fixed and Flag-tagged G9a protein localization
was assessed by indirect immunofluorescence. The nuclear histone 2B protein was used as a control. Cells with both nuclear and cytoplasmic (n+c) or nuclear
only (n) G9a localization are shown.
(C) Expression levels of the E10- or E10+ G9a isoforms were determined by western blot in transfected HeLa (left) or N2a cells (right).
(D and E) Bars show the percentage of HeLa (D) and N2a cells (E) with n+c or n G9a signal (n = between 31 and 208 cells). Scale bars represent 10 mm. Statistical
analysis corresponds to Fisher exact test (*p < 0.05).confirmed indirectly inFigure5anddirectly byevaluating the local-
ization of flag-tagged G9a, containing or lacking E10, transiently
expressed in HeLa and N2a cells (Figure 6). Results in Figure 6
can be explained if one takes into account that the overexpressed
recombinant G9a polypeptide does not enter the nucleus alone
but in multisubunit complexes containing GLP and endogenous
G9a polypeptides thatmay ormay not contain E10. This idea is re-
inforced by our evidence that a G9a mutant in which interaction
withGLP is abolished ismoredefective in promoting E10 inclusion
(Figure7D). In this context, it is predictable that the overexpression
ofG9a E10+will change the balance in the percentage of cells dis-
playing the n+c and the n patterns toward the latter. The observa-
tion that G9a is present not only in the nucleus but also in the cyto-
plasm during some conditions may explain some of the G9a
reported interactions with non-histone targets. Indeed, over 500
predicted targets of G9a and GLP have been identified, more
than50%ofwhichdonot localize in thenucleus (Islametal., 2013).
A relevant report was published aimed at studying the roles of
alternative splicing both of G9a and the heterochromatin histone
methyltransferase SUV39H2 (Mauger et al., 2015). The authors
found that inclusion of SUV39H2 alternative exon 3 is key for
the subnuclear localization and catalytic activity of this enzyme.2804 Cell Reports 14, 2797–2808, March 29, 2016 ª2016 The AuthorRegarding the inclusion of E10 inG9a, similarly to our results ob-
tained in vivo with themethylation FRET reporter, the authors did
not report changes in G9a activity measured in vitro. However,
unlike our findings, the authors did not see differences in the sub-
cellular localization of the E10+ and E10 isoforms, leading them
to conclude that since the levels of E10 inclusion vary greatly in
different cell types, alternative splicing of E10must be controlling
G9a properties other than its methyltransferase activity or local-
ization. The contrasting observations may relay on different
models of study.
Our results reveal a positive feedback loop in which E10 inclu-
sion increases during neuronal differentiation and favors G9a nu-
clear localization, subsequently upregulating E10 inclusion (Fig-
ure 7F). We propose that G9a triggers a positive loop that helps
maintaining the genetic expression program and, thus, rein-
forces the cellular commitment to neuron differentiation.EXPERIMENTAL PROCEDURES
Cell Culture and Treatments
N2a cells were grown in DMEM, with high glucose and pyruvate (Invitrogen),
supplemented with 10% fetal bovine serum (FBS). For differentiation withs
Figure 7. G9a Methyltransferase Activity Is
Involved in the Regulation of Its Own Alter-
native Splicing
(A) N2a cells were differentiated with 1 mM RA for
3 days and treated with vehicle or 3 mM BIX. Cells
were then harvested, RNA was extracted, and
alternative splicing of G9a was assessed as
described in Figure 2. See also Figure S3.
(B–D) Cells were co-transfected with a reporter
minigene for E10 alternative splicing together with
expression plasmids encoding mouse E10, E10+
G9a full-length cDNAs, or the corresponding empty
vectors. In (C), a catalyticmutant versionof theE10+
G9a isoformwas tested inHeLacells, and in (D), two
catalytic mutant versions of the E10+ G9a isoform
were tested in G9a CRISPR-ablated HEK293 cells.
RT-PCR gels are shown at the top and the corre-
sponding quantification at the bottom.
(E) The effect of 3 mM BIX was assayed, and re-
sults are shown normalized to values with empty
vector for vehicle or BIX treatment. Cells were
harvested 48 hr after transfection, and alternative
splicing of G9a was assessed by radioactive RT-
PCR using minigene-specific primers.
(F) Model for the roles of G9a alternative splicing.
In undifferentiated cells, the prevalence of E10
exclusion isoform of G9a correlates with low
nuclear localization signal of the protein. Being
required for neuron differentiation, G9a preferen-
tially localizes to the nucleus upon differentiation,
correlating with an alternative splicing pattern of
the G9a gene that favors the E10+ G9a form. This
change is accompanied by increased levels of
H3K9 methylation of the G9a gene and requires
G9a methyltransferase activity, suggesting a
positive feedback loop in which G9a regulates its
own alternative splicing.
All experiments were performed in triplicate, and
means and SE of representative experiments are
shown. Statistical analysis corresponds to one-
way or two-way ANOVA, Bonferroni post hoc test
(*p < 0.05, **p < 0.001, and ***p < 0.0001). See also
Figures S4 and S5.DMSO, 200,000 cells were plated and the next day were washed once with
PBS and incubated for 4 to 8 days in the same medium but with 0.2% serum
and 2% DMSO. For differentiation with RA, 200,000 cells were plated and the
next day washed once with PBS and incubated for 1–3 days in the same
medium without pyruvate and with 1 mM RA.
P19 cells were grown in a-minimum essential medium (Invitrogen) supple-
mented with 7.5% newborn calf serum and 2.5% fetal calf serum. For differen-
tiation to neural cells, P19 supplemented with 10% FBS were subjected to
treatment with RA to induce the cells to form embryoid bodies for 4 days.
The disaggregated cells were then plated on polylysine and grown in neuro-
basal medium supplemented with B27 for 3–4 more days.
For BIX 01294 (Sigma) treatment, drug or vehicle was added to differenti-
ated cells with RA or to undifferentiated cells plated at low confluence andCell Reports 14, 2797–2808left for 2–3 days. In order to address the role of
G9a during neuron differentiation, treatment with
BIX or siG9a was performed prior to the differen-
tiation process. 6 hr after transfection/treatment,
neuron differentiation was induced with RA.
For 5-azacytidine (Sigma) treatment, drug or
vehicle was added to differentiated cells withDMSO at day 5–6 or to undifferentiated cells plated at low confluence and
left for 3 days. For trichostatin A (Sigma) treatments, the drug or vehicle was
left overnight (16 hr) at day 6–7 in differentiated cells with DMSO or undifferen-
tiated cells.
For quantification of neuron differentiation, neurite morphology of N2a cells
was monitored. Cells with a total neurite length >2-fold higher than the soma
diameter were considered to be differentiated as previously described (Chen
et al., 2012).
Functionally normal mammary epithelial cells (EpH4) were routinely grown in
DMEM:F-12 (Invitrogen) supplemented with 2%FBS (GIBCO), insulin (5 mg/ml,
Sigma), and gentamicin (50 mg/ml; Invitrogen). At the onset of the experiments,
1 3 105 cells were plated either on plastic 35-mm tissue culture wells or on
Matrigel pre-coated ones in DMEM–F12 medium supplemented with insulin, March 29, 2016 ª2016 The Authors 2805
and the lactogenic hormones hydrocortisone (1 mg/ml; Sigma) and prolactin
(3 mg/ml; Sigma), as well as 2% FBS. After 24 hr, the medium was replaced
with serum-free DMEM:F12 plus insulin and lactogenic hormones, and the
cells weremaintained under these conditions for 6 days, with medium replace-
ment every 48 hr. Upon this treatment, cells undergo a morphogenic process
that leads to the formation of polarized three-dimensional structures that turn
on milk protein gene expression or directly on tissue culture plastic, where this
morphological and functional differentiation does not occur.
RNA Extraction and RT-PCR
Total RNA was extracted using TRI Reagent (Molecular Research Center) ac-
cording to the manufacturer’s protocol. Reverse transcription using M-MLV
reverse transcriptase (Invitrogen) and oligo-dT primer was performed accord-
ing to the provider’s instructions. Analysis of G9a E10 splicing was performed
using semiquantitative radioactive PCR. All PCR conditions and primer se-
quences are available upon request.
siRNA Transfections
For total G9a knockdown, the pool of siRNA oligonucleotides used was siGE-
NOME Mouse Ehmt2 (catalog number M-053728-00-0005; Dharmacon). For
G9a E10+ knockdown, a specific siRNA (Invitrogen) was designed to target
25 nt from the E10 sequence (sense, 50-CCCAGUGAGUGGAGCUGCC
CAGCGA-30; antisense: 50-UCGCUGGGCAGCUCCACUCACUGGG-30 ). 5 ml
20-mMsiRNAwas transfected into cells using Lipofectamine2000 (Life Technol-
ogies) transfection reagent in accordancewith the supplier’s recommendations.
Plasmids
Mouse Flag-G9a E10+, mouse Flag-G9a E10, human G9a E10+ catalytic mu-
tants 1 and 2 were cloned in the pcDNA3 backbone. Mouse pCAG G9a full-
length (G9a E10+ wt) and catalytic mutant (G9a E10+ mut) were kindly donated
byDr.SlimaneandDr. Shinkai. For transfectionassays, 1mgplasmidwas trans-
fected into each well of a 6-wells culture plate using Lipofectamine 2000 re-
agent (Life Technologies) according to the manufacturer’s recommendations.
Antibodies
G9a antibody (#3306) and Flag antibody (#2368) from Cell Signaling were used
in western blot assays, immunofluorescence, and FRET. G9a human antibody
fromGenetex (GTX63007) andG9amouse antibody fromSigma (SAB2700645)
were used in immunofluorescence experiments. H3K9me2 (#07-441) and
H3total (#07-690) from Millipore were used in western blot assays.
Immunofluorescence Microscopy
Cells were grown on coverslips and fixed with 4% paraformaldehyde for
15 min at room temperature. Cells were then permeabilized with 0.1% Triton
X-100 for 5 min at room temperature followed by 30 min of blocking with
1% non-immune normal goat serum (catalog number 50-197Z; Invitrogen).
Coverslips were subsequently incubated for 1 hr in primary antibody and
1 hr in secondary antibody diluted in blocking solution. Coverslips were
mounted with PBS:glycerol 1:1 (v/v). Images were acquired with an Olympus
FV1000 inverted confocal microscope using a 603 oil-immersion objective
and processed using FluoView Viewer software (Olympus).
FRET Imaging and Analysis
HeLa cells were co-transfected with expression plasmids encoding mouse
E10 or E10+ G9a isoforms and a methyltransferase activity reporter (Lin
et al., 2004) based on the CFP/YFP FRET pair. Cells co-transfected with the
FRET reporter and an empty vector were used as control for estimating a basal
FRET. The expression of the E10 or E10+ plasmids was evaluated by immu-
nofluorescence using indirect immunofluorescence with an anti-Flag as a pri-
mary antibody. Images were collected on an Olympus FV1000 inverted
confocal microscope, using a 1003 numerical aperture (NA) 1.4 oil-immersion
objective lens. For each data acquisition, five images were collected using the
FluoView software virtual channel function: a simultaneous acquisition of a
CFP image (440-nm laser, 480- to 495-nm emission filter) and a FRET image
(440-nm laser, 535- to 565-nm emission filter) at the virtual channel at phase 1,
and a sequential acquisition of a YFP image (515-nm laser, 550- and 610-nm
emission filter) and a RED image (635-nm laser, 655- to 755-nm emission filter)2806 Cell Reports 14, 2797–2808, March 29, 2016 ª2016 The Authortogether with a transmitted light image were collected at phase 2. Background
subtraction from all channels was performed before quantitative manipula-
tions of the images. Nuclei segmentation was performed by global threshold-
ing of the RED channel. The FRET ratio was calculated pixel by pixel as RFRET =
FRET/CFP and evaluated for each cell by quantifying mean and SD from pixels
inside nuclei masks.
At each condition, between 29 and 41 cells were analyzed, and the
average FRET ratio was calculated for cells expressing the inclusion or exclu-
sion isoform and for control cells. FRET ratio change was defined as the
relative change with respect to the control cell FRET ratio (FRET ratio
change = (R ISOFORM FRET  R CONTROL FRET)/R CONTROL FRET). The nonpara-
metric Wilcoxon rank-sum test was employed to assess whether the different
populations were statistically different.
Disorder Prediction
G9a disordered regions were predicted with the web-based program IUPred
(http://iupred.enzim.hu/), using the long disorder prediction type. IUPred
uses a statistical potential to calculate the energy of each residue in a given
sequence and to assign their order/disorder status (1, 2). This potential was
derived from a dataset of protein with known structures, and the calculated en-
ergy is averaged over a sliding window of 21 residues.
Animals
C57BL/6J mice from the strain of the Bioterio Central, Facultad de Ciencias
Exactas y Naturales (University of Buenos Aires) were used for all experiments.
Animals were kept in a 12:12 hr light:dark cycle with lights on at 6 am, and food
andwater were administered ad libitum. Experimentswere performed in accor-
dance with local regulations and the National Institutes of Health (NIH)Guide of
the Care and Use of Laboratory Animals (NIH publication 80-23/96) and were
previouslyapprovedby theEthicalCommittee (CICUAL)of theFacultaddeCien-
cias Exactas y Naturales, University of Buenos Aires. All efforts were made to
minimize animal suffering and to reduce the number of animals used.
Mice were previously anesthetized with Avertin 2% and then sacrificed by
cervical dislocation at indicated postnatal days (PNDs): PND 1, PND 7, and
PND 120. Whole brain was extracted, rapidly frozen in liquid N2, and stored
at 80C. Isolation of RNA was carried out using TRI-Reagent (Molecular
Research Center), and preparation of cDNA was performed using M-MLV
Reverse Transcriptase (Promega). Alternative splicing of G9a was determined
through PCR as previously described.
Statistical Analysis
GraphPad Prism 5 was used for statistical analysis. One-way or two-way
ANOVA tests were followed by Bonferroni’s corrected multiple comparisons
between pairs of conditions, or TTEST comparisons were used with just two
pair of conditions. Unless otherwise indicated in the figure legends, we
analyzed three biological replicates for each data point in all graphs, and the
level of significance was as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.
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E. (2015). Alternative splicing regulates the expression of G9A and SUV39H2
methyltransferases, and dramatically changes SUV39H2 functions. Nucleic
Acids Res. 43, 1869–1882.
Maze, I., Chaudhury, D., Dietz, D.M., Von Schimmelmann, M., Kennedy, P.J.,
Lobo, M.K., Sillivan, S.E., Miller, M.L., Bagot, R.C., Sun, H., et al. (2014). G9a
influences neuronal subtype specification in striatum. Nat. Neurosci. 17,
533–539.
Naftelberg, S., Schor, I.E., Ast, G., and Kornblihtt, A.R. (2015). Regulation of
alternative splicing through coupling with transcription and chromatin struc-
ture. Annu. Rev. Biochem. 84, 165–198.
Neugebauer, K.M. (2002). On the importance of being co-transcriptional.
J. Cell Sci. 115, 3865–3871.
Nguyen, C.T., Weisenberger, D.J., Velicescu, M., Gonzales, F.A., Lin, J.C.,
Liang, G., and Jones, P.A. (2002). Histone H3-lysine 9 methylation is associ-
ated with aberrant gene silencing in cancer cells and is rapidly reversed by
5-aza-20-deoxycytidine. Cancer Res. 62, 6456–6461.
Ohno, H., Shinoda, K., Ohyama, K., Sharp, L.Z., and Kajimura, S. (2013).
EHMT1 controls brown adipose cell fate and thermogenesis through the
PRDM16 complex. Nature 504, 163–167.
Papasaikas, P., Tejedor, J.R., Vigevani, L., and Valcárcel, J. (2015). Functional
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